12:59 PM EDT, 03/26/2024 (MT Newswires) -- Amazon.com's ( AMZN ) online pharmacy is reaping the benefits of demand for anti-obesity drugs in the US, the Financial Times reported, citing John Love, the head of the business.

Drugs such as Eli Lilly's ( LLY ) Zepbound and Novo Nordisk's ( NVO ) Wegovy would create "a lot of revenue" for Amazon Pharmacy, said Love, the division's general manager and vice president, according to the report.

Both drugs are available directly through Amazon's ( AMZN ) website, the FT said.

Earlier in March, Eli Lilly ( LLY ) and Amazon Pharmacy partnered to deliver widely used prescription drugs through the LillyDirect consumer services. The drugs include Eli Lilly's ( LLY ) obesity, diabetes and migraine headache medicines.

Amazon ( AMZN ) said Tuesday it started same-day delivery for prescription medication in New York and greater Los Angeles using e-bikes, electric vans and drones.

Amazon ( AMZN ) didn't immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 179.56, Change: -0.15, Percent Change: -0.08